Journal of Shandong University (Health Sciences) ›› 2019, Vol. 57 ›› Issue (4): 65-71.doi: 10.6040/j.issn.1671-7554.0.2019.076

Previous Articles    

Application value of combined detection of tumor-associated autoantibodies in the diagnosis of colorectal cancer

GENG Xu, ZHANG Lu, LI Ming, LU Zhiming   

  1. Department of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China
  • Published:2022-09-27

PDF (PC)

179

Abstract: Objective To explore the application value of combined detection of tumor-associated autoantibodies in the diagnosis of colorectal cancer(CRC). Methods The serum specimens and clinical data of CRC patients(CRC group)and precancerous patients(precancerous group)treated in our hospital during May 2017 and November 2017, and the information of healthy controls(control group)were collected. The apurinic/apyrimidinic endonuclease 1(APE1), microtubule associated protein RP/EB family, member 1(MAPRE1)and New York esophageal squamous cell carcinoma 1(NY-ESO-1)autoantibodies levels were detected with enzyme-linked immunosorbent assay(ELISA). The diagnostic efficacies of three autoantibodies and traditional indicators(CEA and CA-199)were analyzed with receiver operating characteristic curve(ROC). Results There were significant differences in the levels of APE1 AAbs, MAPRE1 AAbs and NY-ESO-1 AAbs among the three groups. The area under the curve(AUC)of the 3 autoantibodies(0.772, 95%CI: 0.688-0.856; 0.794, 95%CI: 0.716-0.873; 0.854, 95%CI: 0.778-0.929)were higher than that of CA-199(0.571, 山 东 大 学 学 报 (医 学 版)57卷4期 -耿旭,等.多种肿瘤自身抗体对结直肠癌诊断的应用价值 \=-95%CI: 0.477-0.664, P<0.05). The AUC of NY-ESO-1 AAbs was higher than that of CEA(0.720, 95%CI: 0.639-0.801, P<0.05). The AUC of NY-ESO-1 AAbs + CEA(0.889, 95%CI: 0.829-0.949)was higher than that of NY-ESO-1 AAbs (P=0.03). The AUC of APE1 AAbs+NY-ESO-1 AAbs+CEA(0.927, 95%CI: 0.885-0.970)was statistically higher than that of NY-ESO-1 AAbs+CEA (P=0.04). Conclusion The combined detection of APE1 AAbs, NY-ESO-1 AAbs and CEA can significantly improve the diagnostic efficacy of colorectal cancer, and it is worth clinical application.

Key words: Colorectal cancer, Tumor-associated autoantibody, Apurinic/apyrimidinic endonuclease 1, New York esophageal squamous cell carcinoma 1, Diagnostic efficacy

CLC Number: 

  • R446
[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424.
[2] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[3] 兰蓝, 赵飞, 蔡玥, 等. 中国居民2015年恶性肿瘤死亡率流行病学特征分析[J]. 中华流行病学杂志, 2018, 39(1): 32-34. LAN Lan, ZHAO Fei, CAI Yue, et al. Epidemiological analysis on mortality of cancer in China, 2015[J]. Chinese Journal of Epidemiology, 2018, 39(1): 32-34.
[4] 陈瑞瑞, 梁红, 何夕昆. 结直肠肿瘤的种族差异性研究进展[J]. 山东医药, 2018, 58(18): 96-98.
[5] Boyle P, Chapman CJ, Holdenrieder S, et al. Clinical validation of an autoantibody test for lung cancer[J]. Ann Oncol, 2011, 22(2): 383-389.
[6] 李波, 李伯安. 自身抗体检测在原发性肝癌诊断中的意义[J]. 中华检验医学杂志, 2016, 39(2): 76-78. LI Bo, LI Boan. The significance of autoantibodies detection for the diagnosis of primary hepatic carcinoma[J]. Chinese Journal of Laboratory Medicine, 2016, 39(2): 76-78.
[7] Zhang SH, Wang LN, Li Z, et al. APE1 polymorphisms are associated with colorectal cancer susceptibility in Chinese Hans[J]. World J Gastroenterol, 2014, 20(26): 8700-8708.
[8] 何乐, 杨宇馨, 张诗珩, 等. 血清APE1自身抗体在结直肠癌诊断中的价值[J].第三军医大学学报, 2016, 38(11): 1297-1301. HE Le, YANG Yuxin, ZHANG Shiheng, et al. Diagnostic value of serum APE1 autoantibodies in colorectal cancer[J]. Journal of Third Military Medical University, 2016, 38(11): 1297-1301.
[9] Dai N, Cao XJ, Li MX, et al. Serum APE1 autoantibodies: a novel potential tumor marker and predictor of chemotherapeutic efficacy in non-small cell lung cancer[J]. PLoS One, 2013, 8(3): e58001. doi:10.1371/journal.pone.00580 01.
[10] Taguchi A, Rho JH, Yan Q, et al. MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas[J]. Cancer Prev Res(Phila), 2015, 8(11): 1112-1119.
[11] Healey GF, Lam S, Boyle P, et al. Signal stratification of autoantibody levels in serum samples and its application to the early detection of lung cancer[J]. J Thorac Dis, 2013, 5(5): 618- 625.
[12] 梁爽, 王晓华, 赵艳明, 等. 直肠癌中肿瘤/睾丸抗原相关基因的表达[J]. 中国实验诊断学, 2011, 15(1): 91-93. LIANG Shuang, WANG Xiaohua, ZHAO Yanming, et al. Expression of cancer-testis antigen-related genes in human colorectal carcinomas[J]. Chinese Journal of Laboratory Diagnosis, 2011, 15(1): 91-93.
[13] Fujiwara S, Wada H, Kawada J, et al. NY-ESO-1 antibody as a novel tumour marker of gastric cancer[J]. Br J Cancer, 2013, 108(5): 1119-1125.
[14] McKeown E, Nelson DW, Johnson EK, et al. Current approaches and challenges for monitoring treatment response in colon and rectal cancer[J]. J Cancer, 2014, 5(1):31-43.
[15] Goldberg EM, Simunovic LM, Drake SL, et al. Comparison of serum CA 19-9 and CEA levels in a population at high risk for colorectal cancer[J]. Hybridoma, 1989, 8(5): 569-575.
[16] Liu W, Wang P, Li Z, et al. Evaluation of tumour-associated antigen(TAA)miniarray in immunodiagnosis of colon cancer[J]. Scand J Immunol, 2009, 69(1): 57-63.
[17] Fan CW, Kuo YB, Lin GP, et al. Development of a multiplexed tumor- associated autoantibody-based blood test for the detection of colorectal cancer[J]. Clin Chim Acta, 2017, 475: 157-163. doi: 10.1016/j.cca.2017.10.022.
[18] Jungbluth AA, Chen YT, Stockert E, et al. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues[J]. Int J Cancer, 2001, 92(6): 856-860.
[19] Huajun W, Ying F, Hongxing Z, et al. Clinical value of combined detection of serum APE1-Aabs and CEACAM-1 in the diagnosis of colorectal cancer[J]. Eur Rev Med Pharmacol Sci, 2018, 22(5): 1286-1289.
[20] 于海跃, 刘正昊, 崔君鹏, 等. APE1基因(Asp148Glu)多态性与结直肠癌易感性之间关系的Meta分析[J]. 临床外科杂志, 2017, 25(10): 41-44. YU Haiyue, LIU Zhenghao, CUI Junpeng, et al. Association between APE1(Asp148Glu)gene polymorphism and colorectal cancer susceptibility: a meta-analysis[J]. Journal of Clinical Surgery, 2017, 25(10): 41-44.
[21] Ladd JJ, Busald T, Johnson MM, et al. Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women[J]. Cancer Prev Res(Phila), 2012, 5(4): 655-664.
[22] Li Y, Song R, Li X, et al. Expression and immunogenicity of NY-ESO-1 in colorectal cancer[J]. Exp Ther Med, 2017, 13(6): 3581-3585.
[23] Chan CC, Fan CW, Kuo YB, et al. Multiple serological biomarkers for colorectal cancer detection[J]. Int J Cancer, 2010, 126(7): 1683-1690.
[24] Baudrin LG, Deleuze JF, How-Kit A. Molecular and computational methods for the detection of microsatellite instability in cancer[J]. Front Oncol, 2018, 8: 621. doi:10.3389/fonc.2018.00621.
[25] Chen W, Frankel WL. A practical guide to biomarkers for the evaluation of colorectal cancer[J]. Mod Pathol,2019. doi: 10.1038/s41379-018-0136-1.
[1] SUN Fuyun, WANG Weipeng, ZHANG Huihui, GENG Yan, AN Xiaoxia, LI Shuangshuang, ZHANG Binbin. Correlation among personality traits and depression, anxiety symptoms in patients after colorectal cancer resection [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 91-96.
[2] DU Tiantian, LI Juan, ZHAO Yinghui, DUAN Weili, WANG Jing, WANG Yunshan, DU Lutao, WANG Chuanxin. Expression profiles of long non-coding RNA LINC02474 and effects on cell proliferation in colorectal cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 57-67.
[3] XIAO Juan, XIAO Qiang, CONG Wei, LI Ting, DING Shouluan, ZHANG Yuan, SHAO Chunchun, WU Mei, LIU Jianing, JIA Hongying. Comparison of diagnostic efficacy of two kinds of thyroid imagine reporting and data systems [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 53-59.
[4] LI Ning, LI Juan, XIE Yan, LI Peilong, WANG Yunshan, DU Lutao, WANG Chuanxin. Expression of LncRNA AL109955.1 in 80 cases of colorectal cancer and its effect on cell proliferation, migration and invasion [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 38-46.
[5] HONG Jiageng, NIE Yangyang, SU Guoqiang. Effects of propofol on proliferation, migration and expressions of Wnt1 and β-catenin in colon cancer cells [J]. Journal of Shandong University (Health Sciences), 2020, 58(11): 53-58.
[6] ZHU Yu, WANG Hongjie, HAN Binbin, FENG Shana, ZHANG Chun, LI Xuexiang, HAN Xiaohong, CUI Wei. A study of serum PIVKA-II in patients with liver metastasis of colorectal cancer [J]. Journal of Shandong University (Health Sciences), 2018, 56(10): 58-63.
[7] WANG Bishi, SHAN Junqi, HOU Qingsheng, GONG Weipeng, ZHU Zhenyu, GUO Hongliang. Effort of CD11b+ / CD66b- phenotype myeloid cells on the progression of colon cancer and liver metastasis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 41-45.
[8] FANG Qian, QU Ailin, ZHANG Xin, DU Lutao, YANG Yongmei, WANG Chuanxin. Expression and clinical significance of miR-210 in the serum of patients with colorectal cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(6): 77-81.
[9] LI Jian-ping, MIAO Yu-feng, CHEN Ping, CHEN Su-rong, LIU Hongqi. Use of raltitrexed combined with oxaliplatin or irinotecan as second-line chemotherapy for advanced colorectal cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(S1): 49-50.
[10] ZHANG Yanli, LIU Xinfeng, ZHANG Xin, WANG Haiyan, YANG Yongmei, DU Lutao, WANG Lili, LI Peilong, WANG Chuanxin. Expression of circulating miR-128 in serum of colorectal cancer and its effect on migration and invasion of colorectal cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(8): 57-62.
[11] LIU Wenhui, LI Xiaoling, YUAN Ping, LUAN Rongsheng, FENG Fei, HU Xiaoqin, YAN Jin, YANG Yanfang. Genetic polymorphisms of ADIPOQ and CAPN-10 and colorectal cancer risk [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(11): 106-112.
[12] FENG Fei1, YAN Jin2, YUAN Ping1, HU Xiao-qin1, XU Lin2, YANG Yan-fang1. Relationships between dietary, lifestyle and colorectal cancer： a matched casecontrol study [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(7): 107-112.
[13] LIU Hui， DU Lu-tao， YANG Yong-mei, DONG Zhao-gang, LI Juan, LIU Yi-min, ZHANG Xin, WANG Li-li, ZHENG Gui-xi, WANG Chuan-xin. Expression of miR-182 in colorectal cancer and its effect on the migration of colorectal cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(12): 70-74.
[14] FAN Zhi-bin1， YU Wei-fang2, ZHANG Li-jing1， LIU Bo1， WU Chen-peng3，ZHANG Xue-ming4， ZHAO Zeng-ren1. Expression of microRNA-150 in colorectal carcinoma and its clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(11): 85-89.
[15] YUAN Zhi-ping1, MU Hua-ping2, WANG Qiu1, WANG Li-shuai1, CHEN Jie1,ZHANG Chuan-li1, ZHOU Guang-yuan1, CHEN Jia-lian1. VEGF and sICAM-1 protein expressions and their clinical significance in serum of patients with colorectal cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(10): 74-76.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd